Mechanistic study on how the Tet1/ARF-p53 pathway affects idiopathic pulmonary fibrosis through macrophage

Peng Zhang1, Xiaotong Guo1, Ting Wang1

  • 1Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, 804 Shengli South Street, Xingqing District, Yinchuan, 750004, China.

PubMed
Abstract

Insights

The Tet1/ARF-p53 pathway regulates macrophage polarization in idiopathic pulmonary fibrosis (IPF). Inhibiting M2 macrophage polarization alleviates IPF progression, suggesting a new therapeutic target.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pathology

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease.
  • Macrophage polarization is implicated in IPF pathogenesis.
  • The Tet1/ARF-p53 pathway's role in IPF remains unclear.

Purpose of the Study:

  • To investigate the mechanism of the Tet1/ARF-p53 pathway in IPF.
  • To determine the pathway's effect on macrophage polarization.
  • To explore potential therapeutic strategies for IPF.

Main Methods:

  • Analysis of macrophage polarization in IPF models.
  • Examination of Tet1, ARF, and p53 expression in vitro and in vivo.
  • Quantification of M1 and M2 macrophage markers.

Main Results:

  • Tet1 regulates ARF gene DNA methylation and expression.
  • The Tet1/ARF-p53 pathway impacts macrophage polarization.
  • Inhibition of M2 macrophage polarization alleviates IPF progression.

Conclusions:

  • The Tet1/ARF-p53 pathway is a key regulator of macrophage polarization in IPF.
  • This pathway represents a novel therapeutic target for IPF treatment.